MIAMI BEACH (MedPage Today) -- A combination asthma treatment under development appears to cause few adverse side effects when compared with monotherapy with corticosteroids or long-acting beta2-agonists, researchers said here.
ACAAI: Novel Combo Therapy Safe in Moderate Persistent Asthma (C...Courtesy MedPage Today Allergy & Immunology Wed, 11/11/2009 - 11:41
MIAMI BEACH (MedPage Today) -- A combination asthma treatment under development appears to cause few adverse side effects when compared with monotherapy with corticosteroids or long-acting beta2-agonists, researchers said here. More related itemsAnti-Leukotrienes as Good as Standard Asthma Therapy...
Respiratory Drug Boosts Diabetes Risk (CME/CE)
FDA Approves First-of-a-Kind Asthma Device
|
Popular by tags Week |
Post new comment